0 CHECKOUT

PRODUCT FILTERS

REGION

33
27
26
26
26

COUNTRY

11
6
6
6
5

CATEGORIES

  • 42
  • 42
  • 13
  • 7
  • 6
  • 6
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

26
29
32
98

PUBLISHED

2
13
18
98

PRODUCT TYPE

66
25
4
1
1
1

Search for: "Proteomics of the Nervous System"

Proteomics - Technologies, Markets and Companies

This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in the post-genomic era - the first...

Published:  January 2016
Price:  From

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

Published:  January 2016
Price:  From

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

Published:  January 2016
Price:  From

Molecular Diagnostics - Technologies, Markets and Companies

This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological...

Published:  January 2016
Price:  From

Developmental Genomics of Ascidians

The simplicity and lack of redundancy in their regulatory genes have made ascidians one of the most useful species in studying developmental genomics. In Developmental Genomics of Ascidians, Dr. Noriyuki...

Published:  January 2014
Price: 

Cell Therapy - Technologies, Markets and Companies

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is...

Published:  January 2016
Price:  From

Biomarkers - Global Strategic Business Report

This report analyzes the worldwide markets for Biomarkers in US$ Million by the following Technologies and Services: Technologies - Emerging Biomarker Technologies (Imaging biomarkers, Proteomics, Transcriptomics,...

Published:  August 2011
Price:  From

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

Published:  January 2016
Price:  From

Antiviral Therapeutics - Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical...

Published:  January 2016
Price:  From

Nitric Oxide - Therapeutics, Markets and Companies

This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Major segments of the market for nitric oxide-based...

Published:  January 2016
Price:  From

Global Central Nervous System (CNS) Biomarkers by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 - 2021

A biomarker is biological feature that can be used to measure the presence or progress of disease or the effects of treatment. For example, prostate specific antigen (PSA) is a biomarker for cancer...

Published:  November 2015
Price:  From

Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies

Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies takes a look at the current strategies, successes and challenges involved with the development of novel formulations of biologics,...

Published:  January 2015
Price: 

Neuroprotection - Drugs, Markets and Companies

This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many...

Published:  January 2016
Price:  From

Global Royalty Financing Deals in Pharma, Biotech and Diagnostics 2010-2015

The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2005-2015 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed,...

Published:  June 2015
Price:  From

Cytogenetics - Technologies, Markets and Companies

This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular...

Published:  January 2016
Price:  From

Bone Cancer. Edition No. 2

Bone Cancer, 2nd Edition comprehensively investigates key discoveries in the field of bone biology over the last five years that have led to the development of entirely new areas for investigation,...

Published:  August 2014
Price: 

Sturkie's Avian Physiology. Edition No. 6

Sturkie's Avian Physiology is the classic comprehensive single volume on the physiology of domestic as well as wild birds. The Sixth Edition is thoroughly revised and updated, and features several new...

Published:  August 2014
Price: 

Pharmacogenomics Partnering Terms and Agreements

The Pharmacogenomics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomics partnering deals and agreements entered into by the...

Published:  November 2014
Price:  From

09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in September 2012. All companies include technology, market(s), key...

Published:  September 2012
Price:  From

Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering...

Published:  November 2014
Price:  From
Loading Indicator

Our Clients

  • NBC Universal Inc.
  • Samsung Group Ltd.
  • E.ON SE
  • DHL International GmbH
  • University of Cambridge
  • Kone Oyj
  • BP Plc.